Small vessel thrombosis without major thrombotic events in systemic lupus erythematosus patients with antiphospholipid syndrome

被引:0
作者
Sipek-Dolnicar, A
Hojnik, M
Rozman, B
Vizjak, A
Ferluga, D
机构
[1] Univ Ljubljana, Med Ctr, Dept Rheumatol, Ljubljana 61000, Slovenia
[2] Univ Ljubljana, Fac Med, Inst Pathol, Ljubljana, Slovenia
关键词
anticardiolipin antibodies; systemic lupus erythematosus; antiphospholipid syndrome; thrombosis; thrombotic thrombocytopenic purpura;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Antiphospholipid syndrome has been defined by the presence of antiphospholipid antibodies or lupus anticoagulant in association with certain clinical events, including recurrent arterial or venous thromboses and recurrent fetal loss. It comprises two separate clinical entities: simple, characterized by large vessel occlusions, and catastrophic, with multiple occlusive events predominantly affecting small vessels. Three patients with systemic lupus erythematosus and permanently increased IgG anticardiolipin antibody levels are being described. Only postmortem histopathological examination revealed microangiopathic thrombotic changes in different organs, which were clinically silent in early stages of the disease and misinterpreted later in its course because of a peculiar clinical picture. All patients presented features of catastrophic antiphospholipid syndrome in the final stage of the disease.
引用
收藏
页码:707 / 710
页数:4
相关论文
共 50 条
  • [21] Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus
    Ilgen, U.
    Yayla, M. E.
    Ates, A.
    Okatan, I. E.
    Yurteri, E. U.
    Torgutalp, M.
    Kelesoglu, A. B. D.
    Turgay, T. M.
    Kinikli, G.
    LUPUS, 2018, 27 (04) : 665 - 669
  • [22] Primary antiphospholipid syndrome evolving into systemic lupus erythematosus
    Derksen, RHWM
    GmeligMeijling, FHJ
    deGroot, PG
    LUPUS, 1996, 5 (01) : 77 - 80
  • [23] Intracranial venous thrombosis and pulmonary embolism with antiphospholipid syndrome in systemic lupus erythematosus
    Yuen, SF
    Lau, KF
    Steinberg, AW
    Grattan-Smith, PJ
    Hodson, EM
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2001, 37 (04) : 405 - 408
  • [24] Administration of vasaprostan in patients with systemic lupus erythematosus with antiphospholipid syndrome
    Reshetnyak, TM
    Alekberova, ZS
    Nasonova, VA
    TERAPEVTICHESKII ARKHIV, 1999, 71 (05) : 40 - 47
  • [25] Comorbidities of antiphospholipid syndrome and systemic lupus erythematosus in children
    Akca, Ummusen Kaya
    Ayaz, Nuray Aktay
    CURRENT RHEUMATOLOGY REPORTS, 2020, 22 (06)
  • [26] Risk Factors for Thrombosis and Primary Thrombosis Prevention in Patients With Systemic Lupus Erythematosus With or Without Antiphospholipid Antibodies
    Tektonidou, Maria G.
    Laskari, Katerina
    Panagiotakos, Demosthenes B.
    Moutsopoulos, Haralampos M.
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (01): : 29 - 36
  • [27] Thrombotic risk assessment in patients with systemic lupus erythematosus: Validation of the adjusted-Global Antiphospholipid Syndrome Score (aGAPSS) in Thai patients
    Chanloung, Wanitcha
    Kasitanon, Nuntana
    Wichainun, Ramjai
    Louthrenoo, Worawit
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2021, 24 (12) : 1510 - 1519
  • [28] Pregnancy in systemic lupus erythematosus and antiphospholipid syndrome
    Fischer-Betz, Rebecca
    Specker, Christof
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2017, 31 (03): : 397 - 414
  • [29] IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus
    Reshetnyak, Tatiana
    Cheldieva, Fariza
    Cherkasova, Maria
    Lila, Alexander
    Nasonov, Evgeny
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
  • [30] The impact of antiphospholipid antibodies/antiphospholipid syndrome on systemic lupus erythematosus
    Venturelli, Veronica
    Abrantes, Ana Mafalda
    Rahman, Anisur
    Isenberg, David A.
    RHEUMATOLOGY, 2024, 63 (SI) : SI72 - SI85